Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| QL1706 With Olaparib for Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency (HRD) (NCT07113964) | The First Affiliated Hospital with Nanjing Medical University | 2025-08-30 |
Track Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency automatically
Every clearance here is in the API, with alerts when new ones post.